Cocrystal Pharma, Inc. (COCP) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
COCP Revenue Growth
COCP Revenue Analysis (2013–2024)
As of May 8, 2026, Cocrystal Pharma, Inc. (COCP) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, COCP's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $6.6 million in 2019.
When compared to Healthcare sector peers including AGEN (+10.4% YoY), ABUS (+128.2% YoY), and RDVT (+18.1% YoY). Compare COCP vs AGEN →
COCP Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| COCPCurrent | $0 | - | - | - | |
 AGEN | $114M | +10.4% | +5.3% | -18.0% | |
 ABUS | $14M | +128.2% | +15.3% | -271.0% | |
 RDVT | $90M | +18.1% | +21.1% | 14.6% | |
 RLAY | $15M | +39.0% | -28.6% | -1971.6% | |
 GILD | $29.4B | +3.5% | +3.6% | 40.1% |
COCP Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-12,537,000 | - | $-17,878,000 | - |
| 2023 | $0 | - | $-15,169,000 | - | $-18,559,000 | - |
| 2022 | $0 | - | $-12,392,000 | - | $-38,829,000 | - |
| 2021 | $0 | -100.0% | $-8,794,000 | - | $-14,221,000 | - |
| 2020 | $2.0M | -69.3% | $-4,020,000 | -199.6% | $-9,586,000 | -476.0% |
| 2019 | $6.6M | - | $2.6M | 39.0% | $-48,406,000 | -737.4% |
| 2018 | $0 | - | $-50,000 | - | $-62,924,000 | - |
| 2017 | $0 | - | $-101,000 | - | $-8,262,000 | - |
| 2016 | $0 | -100.0% | $-201,000 | - | $-105,819,000 | - |
| 2015 | $78K | +766.7% | $-114,000 | -146.2% | $-53,948,000 | -69164.1% |
See COCP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs COCP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare COCP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCOCP — Frequently Asked Questions
Quick answers to the most common questions about buying COCP stock.
Is COCP's revenue growth accelerating or slowing?
COCP TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is COCP's long-term revenue growth rate?
Cocrystal Pharma, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is COCP's revenue distributed by segment?
COCP reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.